Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia

ISME Journal - Tập 10 Số 6 - Trang 1456-1470 - 2016
Laure B. Bindels1, Audrey M. Neyrinck1, Sandrine P. Claus2, Caroline Le Roy2, Corinne Grangette3, Bruno Pot3, Inés Martínez4, Jens Walter4,5, Patrice D. Cani1,6, Nathalie M. Delzenne1
1Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium
2Department of Food and Nutritional Sciences, University of Reading, Reading, UK
3Lactic Acid Bacteria and Mucosal Immunity, Centre for Infection and Immunity of Lille, INSERM U1019-CNRS UMR 8204, Institut Pasteur de Lille, Université Lille Nord de France , Lille, France
4Department of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada
5Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada
6Walloon Excellence in Life sciences and BIOtechnology (WELBIO), Louvain Drug Research Institute, UCL , Brussels, Belgium

Tóm tắt

Abstract Cancer cachexia is a multifactorial syndrome that includes muscle wasting and inflammation. As gut microbes influence host immunity and metabolism, we investigated the role of the gut microbiota in the therapeutic management of cancer and associated cachexia. A community-wide analysis of the caecal microbiome in two mouse models of cancer cachexia (acute leukaemia or subcutaneous transplantation of colon cancer cells) identified common microbial signatures, including decreased Lactobacillus spp. and increased Enterobacteriaceae and Parabacteroides goldsteinii/ASF 519. Building on this information, we administered a synbiotic containing inulin-type fructans and live Lactobacillus reuteri 100-23 to leukaemic mice. This treatment restored the Lactobacillus population and reduced the Enterobacteriaceae levels. It also reduced hepatic cancer cell proliferation, muscle wasting and morbidity, and prolonged survival. Administration of the synbiotic was associated with restoration of the expression of antimicrobial proteins controlling intestinal barrier function and gut immunity markers, but did not impact the portal metabolomics imprinting of energy demand. In summary, this study provided evidence that the development of cancer outside the gut can impact intestinal homeostasis and the gut microbial ecosystem and that a synbiotic intervention, by targeting some alterations of the gut microbiota, confers benefits to the host, prolonging survival and reducing cancer proliferation and cachexia.

Từ khóa


Tài liệu tham khảo

Argiles, 2014, Cancer cachexia: understanding the molecular basis, Nat Rev Cancer, 14, 754, 10.1038/nrc3829

Arpaia, 2013, Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation, Nature, 504, 451, 10.1038/nature12726

Arthur, 2012, Intestinal inflammation targets cancer-inducing activity of the microbiota, Science, 338, 120, 10.1126/science.1224820

Atarashi, 2013, Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota, Nature, 500, 232, 10.1038/nature12331

Baracos, 2012, Survival: the relevant primary outcome for nutrition therapy in cancer patients, Curr Opin Clin Nutr Metab Care, 15, 211, 10.1097/MCO.0b013e328352dc41

Bevins, 2011, Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis, Nat Rev Microbiol, 9, 356, 10.1038/nrmicro2546

Bindels, 2012, Restoring Specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model, PLoS One, 7, e37971, 10.1371/journal.pone.0037971

Bindels, 2015, Towards a more comprehensive concept for prebiotics, Nat Rev Gastroenterol Hepatol, 12, 303, 10.1038/nrgastro.2015.47

Bindels, 2013, Muscle wasting: The gut microbiota as a new therapeutic target?, Int J Biochem Cell Biol, 45, 2186, 10.1016/j.biocel.2013.06.021

Bindels, 2012, Gut microbiota-derived propionate reduces cancer cell proliferation in the liver, Br J Cancer, 107, 1337, 10.1038/bjc.2012.409

Brestoff, 2013, Commensal bacteria at the interface of host metabolism and the immune system, Nat Immunol, 14, 676, 10.1038/ni.2640

Cani, 2009, Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, Gut, 58, 1091, 10.1136/gut.2008.165886

Caporaso, 2010, QIIME allows analysis of high-throughput community sequencing data, Nat Methods, 7, 335, 10.1038/nmeth.f.303

Claesson, 2012, Gut microbiota composition correlates with diet and health in the elderly, Nature, 488, 178, 10.1038/nature11319

Cole, 2014, Ribosomal Database Project: data and tools for high throughput rRNA analysis, Nucleic Acids Res, 42, D633, 10.1093/nar/gkt1244

Collison, 2007, The inhibitory cytokine IL-35 contributes to regulatory T-cell function, Nature, 450, 566, 10.1038/nature06306

Crawford, 2009, Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation, Proc Natl Acad Sci USA, 106, 11276, 10.1073/pnas.0902366106

Dewhirst, 1999, Phylogeny of the defined murine microbiota: altered Schaedler flora, Appl Environ Microbiol, 65, 3287, 10.1128/AEM.65.8.3287-3292.1999

Dewulf, 2013, Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women, Gut, 62, 1112, 10.1136/gutjnl-2012-303304

Edgar, 2013, UPARSE: highly accurate OTU sequences from microbial amplicon reads, Nat Methods, 10, 996, 10.1038/nmeth.2604

Eren, 2013, A filtering method to generate high quality short reads using illumina paired-end technology, PLoS One, 8, e66643, 10.1371/journal.pone.0066643

Eriguchi, 2012, Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of alpha-defensins, Blood, 120, 223, 10.1182/blood-2011-12-401166

Everard, 2014, Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity, ISME J, 8, 2116, 10.1038/ismej.2014.45

Fearon, 2013, Understanding the mechanisms and treatment options in cancer cachexia, Nat Rev Clin Oncol, 10, 90, 10.1038/nrclinonc.2012.209

Fearon, 2012, Cancer cachexia: mediators, signaling, and metabolic pathways, Cell Metab, 16, 153, 10.1016/j.cmet.2012.06.011

Foligne, 2007, Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria, World J Gastroenterol, 13, 236, 10.3748/wjg.v13.i2.236

Gavin, 2007, Foxp3-dependent programme of regulatory T-cell differentiation, Nature, 445, 771, 10.1038/nature05543

Gibson, 2004, Dietary modulation of the human colonic microbiota: updating the concept of prebiotics, Nutr Res Rev, 17, 259, 10.1079/NRR200479

Gibson, 1995, Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics, J Nutr, 125, 1401, 10.1093/jn/125.6.1401

Hooper, 2012, Interactions between the microbiota and the immune system, Science, 336, 1268, 10.1126/science.1223490

Inaba, 2010, Expression of the antimicrobial peptide alpha-defensin/cryptdins in intestinal crypts decreases at the initial phase of intestinal inflammation in a model of inflammatory bowel disease, IL-10-deficient mice, Inflamm Bowel Dis, 16, 1488, 10.1002/ibd.21253

Ivanov, 2010, Cytoskeletal regulation of epithelial barrier function during inflammation, Am J Pathol, 177, 512, 10.2353/ajpath.2010.100168

Ivanov, 2009, Induction of intestinal Th17 cells by segmented filamentous bacteria, Cell, 139, 485, 10.1016/j.cell.2009.09.033

Kolida, 2011, Synbiotics in health and disease, Annu Rev Food Sci Technol, 2, 373, 10.1146/annurev-food-022510-133739

Krumbeck, 2015, Introducing the concept of In Vivo Selection to identify bacterial stains with enhanced ecological performance when used in synbiotic applications, Appl Environ Microbiol, 81, 2455, 10.1128/AEM.03903-14

Lawley, 2013, Intestinal colonization resistance, Immunology, 138, 1, 10.1111/j.1365-2567.2012.03616.x

Lin, 2012, Irinotecan (CPT-11) Chemotherapy Alters Intestinal Microbiota in Tumour Bearing Rats, PLoS One, 7, e39764, 10.1371/journal.pone.0039764

Livingston, 2010, Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response, Immunol Cell Biol, 88, 99, 10.1038/icb.2009.71

Louis, 2014, The gut microbiota, bacterial metabolites and colorectal cancer, Nat Rev Microbiol, 12, 661, 10.1038/nrmicro3344

Lupp, 2007, Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae, Cell Host Microbe, 2, 204, 10.1016/j.chom.2007.08.002

Manichanh, 2012, The gut microbiota in IBD, Nat Rev Gastroenterol Hepatol, 9, 599, 10.1038/nrgastro.2012.152

Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205

Mukherjee, 2015, Antimicrobial defense of the intestine, Immunity, 42, 28, 10.1016/j.immuni.2014.12.028

Puppa, 2011, Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia, Biochim Biophys Acta, 1812, 1601, 10.1016/j.bbadis.2011.08.010

Rubtsov, 2008, Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces, Immunity, 28, 546, 10.1016/j.immuni.2008.02.017

Schloss, 2009, Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities, Appl Environ Microbiol, 75, 7537, 10.1128/AEM.01541-09

Schnupf, 2015, Growth and host interaction of mouse segmented filamentous bacteria in vitro, Nature, 520, 99, 10.1038/nature14027

Schwabe, 2013, The microbiome and cancer, Nat Rev Cancer, 13, 800, 10.1038/nrc3610

Sciorati, 2009, Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wasting, J Cell Sci, 122, 1119, 10.1242/jcs.041665

Segata, 2011, Metagenomic biomarker discovery and explanation, Genome Biol, 12, R60, 10.1186/gb-2011-12-6-r60

Sha, 2014, Preventive effects of Escherichia coli strain Nissle 1917 with different courses and different doses on intestinal inflammation in murine model of colitis, Inflamm Res, 63, 873, 10.1007/s00011-014-0761-1

Song, 2005, “Bacteroides goldsteinii sp. nov.” isolated from clinical specimens of human intestinal origin, J Clin Microbiol, 43, 4522, 10.1128/JCM.43.9.4522-4527.2005

Talbert, 2014, Modeling human cancer cachexia in colon 26 tumor-bearing adult mice, J Cachexia Sarcopenia Muscle, 5, 321, 10.1007/s13539-014-0141-2

Tilg, 2014, Microbiota and diabetes: an evolving relationship, Gut, 63, 1513, 10.1136/gutjnl-2014-306928

Veiga, 2010, Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes, Proc Natl Acad Sci USA, 107, 18132, 10.1073/pnas.1011737107

von Haehling, 2014, Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014, J Cachexia Sarcopenia Muscle, 5, 261, 10.1007/s13539-014-0164-8

Winter, 2013, Host-derived nitrate boosts growth of E. coli in the inflamed gut, Science, 339, 708, 10.1126/science.1232467

Thông tin
Thông tin xuất bản

ISME Journal

Tập 10 Số 6

1456-1470

Thông tin tác giả